Genetics and gut health reshape life, from income to cancer risks

New research highlights the wide-ranging influence of genetics and gut health on human life. These findings extend beyond physical traits, touching on education, income, and disease prevention. Meanwhile, concerns grow over the exclusion of pregnant women from drug trials and the impact of climate change on allergies. Dalton Conley’s new book, The Social Genome, examines how genes can predict aspects of life such as education and income. This goes far beyond traditional genetic associations with physical characteristics.

Gut health also plays a critical role in hormone regulation. Specific gut bacteria and enzymes control estrogen circulation in the body. Disruptions in these microbial communities can lead to excess estrogen, which is linked to breast and endometrial cancers. People in industrial societies and formula-fed babies show a greater ability to recycle discarded estrogen.

In clinical research, 75% of drug trials over the past 15 years excluded pregnant women. This exclusion, often for safety reasons, limits data on drug safety and effectiveness for this group. Experts argue that including pregnant women in trials could provide clearer guidance on medication use during pregnancy.

Climate change is set to worsen allergy seasons as well. Researchers estimate an additional 19 days of high pollen counts, leading to longer and more intense allergy periods. These discoveries underscore the interconnectedness of genetics, gut health, and environmental factors. Adjusting drug trial policies could improve medical outcomes for pregnant women. At the same time, managing gut bacteria may help prevent hormone-related diseases, while climate shifts demand greater attention to public health strategies.